CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 174 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $922,000 | +101.8% | 58,790 | +35.6% | 0.45% | +90.3% |
| Q3 2015 | $457,000 | -88.9% | 43,345 | -73.4% | 0.24% | -87.1% |
| Q2 2015 | $4,115,000 | -9.6% | 163,145 | -0.1% | 1.84% | -12.8% |
| Q1 2015 | $4,552,000 | +27.7% | 163,345 | -16.4% | 2.11% | +23.8% |
| Q4 2014 | $3,565,000 | +308.4% | 195,345 | +190.1% | 1.70% | +289.9% |
| Q3 2014 | $873,000 | – | 67,330 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |